Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Free Cash Flow (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Free Cash Flow for 14 consecutive years, with -$1.6 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 908.54% to -$1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.3 million through Dec 2025, down 194.34% year-over-year, with the annual reading at -$4.3 million for FY2025, 194.34% down from the prior year.
  • Free Cash Flow hit -$1.6 million in Q4 2025 for STRATA Skin Sciences, down from -$24000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $974000.0 in Q2 2021 to a low of -$2.6 million in Q1 2023.
  • Historically, Free Cash Flow has averaged -$902650.0 across 5 years, with a median of -$821500.0 in 2022.
  • Biggest five-year swings in Free Cash Flow: soared 157.35% in 2024 and later tumbled 908.54% in 2025.
  • Year by year, Free Cash Flow stood at -$461000.0 in 2021, then tumbled by 229.72% to -$1.5 million in 2022, then skyrocketed by 77.17% to -$347000.0 in 2023, then skyrocketed by 157.35% to $199000.0 in 2024, then crashed by 908.54% to -$1.6 million in 2025.
  • Business Quant data shows Free Cash Flow for SSKN at -$1.6 million in Q4 2025, -$24000.0 in Q3 2025, and -$1.9 million in Q2 2025.